Hoth Therapeutics, Inc.
General ticker "HOTH" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $11.1M (TTM average)
Hoth Therapeutics, Inc. follows the US Stock Market performance with the rate: 34.6%.
Estimated limits based on current volatility of 3.5%: low 1.16$, high 1.24$
Factors to consider:
- Total employees count: 6 (0.0%) as of 2023
- Top business risk factors: Operational and conduct risks, Regulatory and compliance, Management team reliance, Acquisition/divestiture risks, Trade secret risks
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.49$, 1.66$]
- 2025-12-31 to 2026-12-31 estimated range: [0.39$, 1.36$]
Financial Metrics affecting the HOTH estimates:
- Positive: with PPE of -0.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -140.28 <= 0.33
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Positive: Shareholder equity ratio, % of 89.19 > 63.39
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Industry operating cash flow (median)
Short-term HOTH quotes
Long-term HOTH plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $11.07MM | $7.69MM | $8.22MM |
| Operating Income | $-11.07MM | $-7.69MM | $-8.22MM |
| Non-Operating Income | $-0.43MM | $0.06MM | $0.03MM |
| R&D Expense | $4.93MM | $3.48MM | $3.25MM |
| Income(Loss) | $-11.49MM | $-7.64MM | $-8.19MM |
| Profit(Loss)* | $-11.37MM | $-7.85MM | $-8.19MM |
| Stockholders Equity | $5.12MM | $8.82MM | $6.88MM |
| Assets | $6.76MM | $9.52MM | $7.71MM |
| Operating Cash Flow | $-9.30MM | $-8.45MM | $-6.98MM |
| Capital expenditure | $0.07MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $1.16MM | $0.01MM | $0.00MM |
| Financing Cash Flow | $6.04MM | $11.32MM | $4.74MM |
| Earnings Per Share** | $-9.50 | $-2.30 | $-1.28 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.